CLLXF Stock UPDATES Callinex Mines Inc (CLLXF) 0.2097 10/29/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Callinex Mines Inc (CLLXF) 0.2097 $CLLXF

Callinex Announces Appointment of New Director
PR Newswire - Mon Mar 31, 12:25PM CDT
Callinex Mines Inc. (CNX - TSX.V) (CLLXF - OTCQX) is pleased to announce the appointment of Peter A. Schriber to the Board of Directors.
CNX.VN: 0.210 (-0.020)

Callinex Mines Inc. - "Neuron" Exploration Property Now Fully Staked
PR Newswire - Fri Jan 17, 2:30PM CST
Callinex Mines Inc. (TSXV: CNX) (OTCQX: CLLXF) is pleased to announce that it has received final title from the Manitoba Department of Mines for the 17,500 hectares of Mineral Exploration Licenses in Northern Manitoba previously reported as having been applied for. This final government approval brings the land package in the district to a total of 44,300 hectares in area. Callinex is the sole holder of the Mineral Exploration Licenses, and several additional mineral claims. The Company has acquired this land package strategically, for the purpose of discovery-oriented graphite exploration.
SD: 3.96 (+0.20), CNX.VN: 0.210 (-0.020)

Callinex Acquires New Mineral Property in Manitoba
PR Newswire - Wed Jan 08, 10:56AM CST
Callinex Mines Inc. (TSX.V:CNX) (OTCQX :CLLXF) has acquired a combined 26,800 hectares of mineral claims and mineral exploration licenses (MEL) in Northern Manitoba near Thompson. The land package was acquired by way of staking. The company has applied for, and expects to be awarded, an additional 17,500 hectares of adjacent MELs.
NICE: 40.38 (+0.16), CNX.VN: 0.210 (-0.020)

Callinex Announces Private Placement to Raise up to $550,000
CNW Group - Wed Sep 04, 5:29PM CDT
Callinex Mines Inc. (TSX.V-CNX) (OTCQX - CLLXF) (the "Company" is pleased to announce that is conducting a private placement of up to 1,571,429 units (each a "Unit" of the Company at the price of $0.35 per Unit. Each Unit will consist of one common share of the Company and one half of a share purchase warrant (a "Warrant" . Each whole Warrant will entitle the holder to purchase one additional common share of the Company for a period of two years from closing the private placement at the price of $0.35 per share in the first year and $0.40 per share in the second year.
CNX.VN: 0.210 (-0.020)

Callinex Mines Inc. - Stock Options Granted
CNW Group - Tue Aug 06, 4:04PM CDT
Callinex Mines Inc. (TSXV: CNX) (OTCQX: CLLXF) (the "Company" announces that it has granted stock options exercisable to purchase 1,410,000 of its shares at a price of $0.30 per share to directors, officers and employees subject to the terms of its current stock option plan. These options will expire August 6(th), 2018.
CNX.VN: 0.210 (-0.020)

Callinex Closes Private Placement To Raise $1,356,000
CNW Group - Thu Jul 25, 5:12PM CDT
Callinex Mines Inc. (TSX.V-CNX) (OTCQX - CLLXF) ("Callinex" is pleased to announce that is has closed its non-brokered private placement to raise proceeds of $1,356,000 by the issuance of 9,040,000 units (the "Units" at a price of $0.15 per Unit. Each Unit consists of one flow-through common share (a "Share" and one share purchase warrant (a "Warrant" . Each Warrant entitles the holder to purchase one non flow-through common share of the Company at the price of $0.20 per share until July 25, 2015.
CNX.VN: 0.210 (-0.020)

Callinex announces increase to private placement
CNW Group - Fri Jul 05, 6:27PM CDT
Callinex Mines Inc. (TSX.V-CNX) (OTCQX - CLLXF) is pleased to announce that, further to its news release dated June 12, 2013, it has increased its private placement offering to up to 9,000,000 units at $0.15 per unit for aggregate proceeds of up to $1,350,000. All other terms of the private placement remain the same. The private placement is subject to acceptance for filing by the TSX Venture Exchange.
CNX.VN: 0.210 (-0.020)

Callinex Announces Private Placement to Raise $1.2 Million
CNW Group - Wed Jun 12, 8:30AM CDT
Callinex Mines Inc. (TSX.V-CNX) (OTCQX - CLLXF) (the "Company" is pleased to announce that it has arranged a private placement of eight million units (each a "Unit" of the Company at the price of $0.15 per Unit. Each Unit will consist of one flow-through common share and one share purchase warrant (a "Warrant" . Each Warrant will entitle the holder to purchase one additional common share of the Company at the price of $0.20 per share for a period of two years from closing the private placement.
CNX.VN: 0.210 (-0.020)

Callinex Proposes to Exercise Option to Acquire Gossan Hill Property
CNW Group - Fri Jun 07, 1:33PM CDT
Callinex Mines Inc. (TSX.V-CNX) (OTCQX - CLLXF) is pleased to announce that it has completed the required work commitment to acquire the Gossan Hill property, near Cranberry Portage, Manitoba. The most recent drill program completed on the property this past March successfully expanded the known mineralization both along strike and at depth (see Callinex news announcement May 10, 2013). As disclosed, this drill program produced core drilling results at very good grades over widths amenable to current mining methods, including a 4.70 metre interval grading 12.99 g/t gold, beginning at a depth of 104.00 metres. Callinex is very encouraged by the work done on the Gossan Hill property to date, and intends to further pursue the property's development.
CNX.VN: 0.210 (-0.020)

Drilling to Re-Commence at Gossan Hill
PR Newswire - Wed Mar 13, 2:11PM CDT
Callinex Mines (TSX.V-CNX) (OTCQX - CLLXF) is pleased to announce that it has begun a drilling campaign on its Gossan Hill gold project in Northern Manitoba near Cranberry Portage. This, the third drill program on the property by Callinex, is designed to build on the success encountered in the 2012 drilling program.
CNX.VN: 0.210 (-0.020)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading